Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Cervical Cancer

  Free Subscription


09.11.2026

1 Afr J Reprod Health
1 Am J Health Stud
1 Am J Trop Med Hyg
1 Ann Afr Med
1 Ann Med
1 Biochim Biophys Acta Gen Subj
1 Bioengineered
1 Biosci Rep
1 BMC Bioinformatics
1 BMC Cancer
1 BMC Health Serv Res
2 BMC Womens Health
1 BMJ Public Health
1 Cancer Biol Med
1 Cancer Manag Res
1 Cancer Med
1 Cancer Rep (Hoboken)
1 Cell Death Discov
1 Cell Oncol (Dordr)
1 Ceska Gynekol
1 Clin Exp Med
1 Contemp Clin Trials
1 Ecotoxicol Environ Saf
1 Epidemiol Rev
1 Exp Cell Res
1 FASEB J
1 Fitoterapia
1 Free Radic Res
1 Front Biosci (Landmark Ed)
3 Front Immunol
3 Front Oncol
1 Front Public Health
1 Funct Integr Genomics
1 Gene
1 Georgian Med News
1 Gynecol Oncol
1 Health Expect
1 Infect Agent Cancer
4 Int J Gynecol Cancer
1 Int Rev Immunol
1 Int Urogynecol J
1 J Appl Clin Med Phys
1 J Biomed Mater Res B Appl Biomater
1 J Cancer Surviv
1 J Cell Biochem
2 J Gynecol Obstet Hum Reprod
1 J Gynecol Oncol
1 J Health Care Poor Underserved
1 J Nutr Sci Vitaminol (Tokyo)
1 J Pak Med Assoc
1 J Proteome Res
1 J Transl Med
1 J Vis Exp
1 JCO Glob Oncol
1 Med Oncol
1 medRxiv
1 Mikrobiyol Bul
1 Mol Biol Rep
1 Nat Med
1 Oncol Lett
1 Oncol Nurs Forum
1 Oncol Res
1 PLoS One
1 Public Health Nurs
1 Radiat Oncol
1 Radiother Oncol
1 Sex Health
1 Turk J Obstet Gynecol
1 Yakugaku Zasshi
1 Zhonghua Bing Li Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Afr J Reprod Health

  1. NASHANDI TN, Downing C
    Cervical cancer awareness among Namibian women: Perspectives of primary healthcare nurses.
    Afr J Reprod Health. 2026;30:31-43.
    PubMed         Abstract available


    Am J Health Stud

  2. ELIZONDO A, Asare M
    Determinants of female college students' likelihood of accepting self-collected samples for cervical cancer prevention.
    Am J Health Stud. 2026;41:42-51.
    PubMed         Abstract available


    Am J Trop Med Hyg

  3. AHMED AA, Abegaz BY, Abdela SG, Abegaz SS, et al
    Uterine Cervical Tuberculosis Mimicking Malignancy: Case Series from Ethiopia.
    Am J Trop Med Hyg. 2026 Sep 22:tpmd250752. doi: 10.4269/ajtmh.25-0752.
    PubMed         Abstract available


    Ann Afr Med

  4. BHONDAVE S, Salvi N
    Open Boari Flap Ureteroneocystostomy in a Radiated Pelvis: A Durable Solution for Complex Distal Ureteric Strictures.
    Ann Afr Med. 2026;25.
    PubMed         Abstract available


    Ann Med

  5. ZHANG J, Ji M, Lv N, Zhou Y, et al
    Cervicovaginal microbiome modulates HPV genotype-specific clearance/persistence: role of bacterial dysbiosis in cervical carcinogenesis.
    Ann Med. 2026;58:2754577.
    PubMed         Abstract available


    Biochim Biophys Acta Gen Subj

  6. XIA M, Xu H, Ding N, Wang X, et al
    Quercetin, an active component of Qiu's HuaShi decoction, suppresses glycolysis in cervical epithelial cells to reduce HPV infection via modulating the PRKACA/cAMP/PKA/CREB pathway.
    Biochim Biophys Acta Gen Subj. 2026;1870:131004.
    PubMed         Abstract available


    Bioengineered


  7. Statement of Retraction: MACC1 regulates the AKT/STAT3 signaling pathway to induce migration, invasion, cancer stemness, and suppress apoptosis in cervical cancer cells.
    Bioengineered. 2026;17:2745772.
    PubMed        


    Biosci Rep

  8. WANG JY, Chen LJ
    Expression of Concern: The role of miRNAs in the invasion and metastasis of cervical cancer.
    Biosci Rep. 2026;46:BSR20181377.
    PubMed        


    BMC Bioinformatics

  9. HAZNEDAR H, Ozsert Yigit G, Haznedar B
    Attentive interpretable tabular learning (TabNet) for miRNA expression classification in cervical cancer and Alzheimer's disease.
    BMC Bioinformatics. 2026;27:264.
    PubMed         Abstract available


    BMC Cancer

  10. HASSAN N, Ullah A, Khan NU, Jan Z, et al
    Integrative genomic and biophysics analysis of MAPK1 rs1057519911 in cervical cancer: genetic association and therapeutic implications.
    BMC Cancer. 2026;26:1349.
    PubMed         Abstract available


    BMC Health Serv Res

  11. EFFAH K, Tekpor E, Wormenor CM, Klutsey GB, et al
    Utilization and outcome estimates of cervical precancer screening and associated factors among female health workers in Ghana: implications for primary screening programs.
    BMC Health Serv Res. 2026;26:1503.
    PubMed         Abstract available


    BMC Womens Health

  12. ZULFEEN M, Howell D, Dogar O
    Barriers to the uptake of cervical cancer screening methods in Low- and Middle-Income Countries (LMICs) - a scoping review using framework thematic analysis.
    BMC Womens Health. 2026;26:589.
    PubMed         Abstract available

  13. CHEN H, Yang C, Wang H
    Correlation between high-risk Human Papillomavirus (HPV) viral load and cervical lesions across different subtypes, along with the development of a clinical prediction model.
    BMC Womens Health. 2026;26:573.
    PubMed         Abstract available


    BMJ Public Health

  14. RUKUNDO-AYEH T, McBain RK, Rasmussen PW, Nakisige C, et al
    Optimising a national screen-and-treat cervical cancer strategy in Uganda: a microsimulation cost-effectiveness and budget impact analysis.
    BMJ Public Health. 2026;4:e005684.
    PubMed         Abstract available


    Cancer Biol Med

  15. YUAN M, Zhao X, Hu S, Zhao S, et al
    Thermal ablation versus loop electrosurgical excision procedure and cold knife conization for cervical intraepithelial neoplasia: efficacy and HPV clearance in a 5-year cohort of Chinese women.
    Cancer Biol Med. 2026;23:1477-94.
    PubMed         Abstract available


    Cancer Manag Res

  16. CHENG T, Niu R, Li X, Gao X, et al
    Evolving Systemic Intensification Strategies Beyond CCRT in Locally Advanced Cervical Cancer.
    Cancer Manag Res. 2026;18:637635.
    PubMed         Abstract available


    Cancer Med

  17. ZHANG L, Sheng P, Cai D, Zhao Z, et al
    Mechanistic Study of GSDME and CXCL10 in SUV39H1-Mediated Pyroptosis and Immune Suppression in Cervical Cancer.
    Cancer Med. 2026;15:e72468.
    PubMed         Abstract available


    Cancer Rep (Hoboken)

  18. HARADA M, Hagiwara Y, Kabasawa T, Sato H, et al
    Carcinoma In Situ Skip Lesions of the Uterine Corpus in Cervical Squamous Cell Carcinoma: Impact on Target Setting in Radiotherapy.
    Cancer Rep (Hoboken). 2026;9:e70751.
    PubMed         Abstract available


    Cell Death Discov

  19. YU CL, Lin CL, Lee HL, Chiou HL, et al
    ESM1-mediated DNMT3A suppresses cervical cancer metastasis through epigenetic regulation of ID3 expression.
    Cell Death Discov. 2026;12:438.
    PubMed         Abstract available


    Cell Oncol (Dordr)

  20. SUN Y, Zhang D, Chen Y, Dai G, et al
    Cucurbitacin I induces pyroptosis via NF-kappaB/TNFR1/caspase-8/caspase-3/GSDME axis for cervical cancer treatment.
    Cell Oncol (Dordr). 2026;49:145.
    PubMed         Abstract available


    Ceska Gynekol

  21. BARTOSOVA M, Kinkorova Lunackova I, Bouda J, Cerna K, et al
    Methylation test versus dual staining in the triage of HR-HPV positive women - pilot data from cervical cancer screening.
    Ceska Gynekol. 2026;91:357-362.
    PubMed         Abstract available


    Clin Exp Med

  22. TANG L, Zhou Z, Zeng G, Wang J, et al
    LRP8 drives cervical cancer lymph node metastasis by promoting epithelial-mesenchymal transition and VEGF-C secretion.
    Clin Exp Med. 2026;26:365.
    PubMed         Abstract available


    Contemp Clin Trials

  23. KARLSEN E, Langlois J, Boucoiran I, Brophy J, et al
    Rationale and design of a clinical trial of a reduced dosing schedule for the nonavalent human papillomavirus vaccine in women living with HIV: The NOVA-HIV study.
    Contemp Clin Trials. 2026;170:108475.
    PubMed         Abstract available


    Ecotoxicol Environ Saf

  24. WEI Z, Wu Y, Li M, Sa S, et al
    Toxicological effects of acetyl tributyl citrate exposure on the progression of uterine fibroids and cervical cancer.
    Ecotoxicol Environ Saf. 2026;326:121014.
    PubMed         Abstract available


    Epidemiol Rev

  25. BEETCH J, Bittencourt L, Gutierrez R, Lovera DC, et al
    Barriers limiting access to follow-up care after HPV screening for cervical cancer in global settings: A systematic review.
    Epidemiol Rev. 2026 Nov 2:mxag017. doi: 10.1093.
    PubMed         Abstract available


    Exp Cell Res

  26. SAYED U, Kubaev A, Polatova D, Ali MK, et al
    TWIST family in cervical cancer biology: From molecular mechanisms to clinical implications.
    Exp Cell Res. 2026 Nov 4:115215. doi: 10.1016/j.yexcr.2026.115215.
    PubMed         Abstract available


    FASEB J

  27. CHEN W, Li S, Wang X, Qian M, et al
    USP22 Facilitates Cervical Cancer Progression via Deubiquitinating and Stabilizing IRAK1 to Activate NF-kappaB Signaling.
    FASEB J. 2026;40:e72419.
    PubMed         Abstract available


    Fitoterapia

  28. YANG F, Yousif M, Okyere SK, Xu J, et al
    Metabolite profiling and antiproliferative activity of endophytic fungus Alternaria alternata Y-13 isolated from Ageratina adenophora against cervical cancer cells.
    Fitoterapia. 2026;195:107531.
    PubMed         Abstract available


    Free Radic Res

  29. WANG R, Liu J
    Baicalein enhances radiosensitivity in cervical cancer by targeting ALOX15 and regulating lipid metabolism.
    Free Radic Res. 2026 Nov 2:1-14. doi: 10.1080/10715762.2026.2756487.
    PubMed         Abstract available


    Front Biosci (Landmark Ed)

  30. YANG H, Ma L, Ma R, Huang D, et al
    Ketone Body Metabolism in Cancer-Associated Fibroblasts and FSTL3 as Prognostic and Therapeutic Determinants of Chemoradiotherapy Response in Cervical Cancer.
    Front Biosci (Landmark Ed). 2026;31:54670.
    PubMed         Abstract available


    Front Immunol

  31. HWANG H, An T, Seo EH, Park PG, et al
    A novel HPV mRNA vaccine candidate: immunogenicity and definition of immune correlates of protection.
    Front Immunol. 2026;17:1925901.
    PubMed         Abstract available

  32. XIAO C, Tian F, Kang M, Xie F, et al
    Dose- and time-resolved immune states in cervical cancer radiotherapy: dynamic multimodal biomarkers for adaptive immunoradiotherapy.
    Front Immunol. 2026;17:1981103.
    PubMed         Abstract available

  33. LUO R, Li M, Ma L, Huang Z, et al
    Efficacy and safety of PD-1/PD-L1 inhibitors plus chemotherapy +/- bevacizumab for recurrent or metastatic cervical cancer: a systematic review and meta-analysis of randomized controlled trials.
    Front Immunol. 2026;17:1972995.
    PubMed         Abstract available


    Front Oncol

  34. BAE J, Kim U, Kang S
    Predicting outcomes in locally advanced cervical cancer treated with radiotherapy: a systematic review of nomograms.
    Front Oncol. 2026;16:1940047.
    PubMed         Abstract available

  35. RACI B, Stojkovska S, Hodolli G, Klisarovska V, et al
    NGAL and traditional biomarkers in cervical cancer: a comparative evaluation using random forest.
    Front Oncol. 2026;16:1933456.
    PubMed         Abstract available

  36. DUAN Y, Liu D, Huang Q, Man J, et al
    Case Report: Prolonged survival with short-course triplet induction and dual maintenance in recurrent/metastatic cervical cancer.
    Front Oncol. 2026;16:1961384.
    PubMed         Abstract available


    Front Public Health

  37. CHEN M, Xiao G, Xiao H, Bai Y, et al
    High-risk factors associated with persistence and progression of cervical intraepithelial neoplasia 2 in women of reproductive age undergoing conservative management: a retrospective analysis.
    Front Public Health. 2026;14:1961644.
    PubMed         Abstract available


    Funct Integr Genomics

  38. ZHENG Y, Yi H, Zhu L, Huang J, et al
    Discovery-locked cross-platform evaluation of a cervical epithelial transcriptional state.
    Funct Integr Genomics. 2026;26:321.
    PubMed         Abstract available


    Gene

  39. AIHEMAITIJIANG F, Meng X, Yumai A, Muhanmude Y, et al
    ZC3H13 promotes cervical cancer cell proliferation and stemness and reduces cisplatin sensitivity and apoptosis by stabilizing CTHRC1 mRNA in an m(6)A-Dependent manner.
    Gene. 2026 Nov 1:150474. doi: 10.1016/j.gene.2026.150474.
    PubMed         Abstract available


    Georgian Med News

  40. KHAMDAMOVA M, Khalilova M, Askarova Z, Yusupova M, et al
    MORPHOLOGICAL FEATURES OF THE CERVICAL EPITHELIUM AND STROMA IN CHRONIC RECURRENT CERVICITIS WITH AND WITHOUT SQUAMOUS INTRAEPITHELIAL LESIONS: A COMPARATIVE CROSS-SECTIONAL STUDY.
    Georgian Med News. 2026;:226-233.
    PubMed         Abstract available


    Gynecol Oncol

  41. FAROLFI A, Casadei C, Strada I, Petracci E, et al
    Human papillomavirus vaccination following cervical intraepithelial neoplasia and subsequent cervical cancer: A retrospective propensity score-matched cohort study.
    Gynecol Oncol. 2026;215:52-57.
    PubMed         Abstract available


    Health Expect

  42. MERRY K, Laheri Z, Johns S, Hirst Y, et al
    Understanding Cervical Screening Engagement Among Young South Asian Women: Perspectives of Women and Healthcare Professionals.
    Health Expect. 2026;29:e70960.
    PubMed         Abstract available


    Infect Agent Cancer

  43. SUN J, Xu Y, Guo K, Feng Q, et al
    Identification of prognostic genes associated with innate lymphoid cells in cervical cancer through bioinformatics analyses and experimental assays.
    Infect Agent Cancer. 2026;21:75.
    PubMed         Abstract available


    Int J Gynecol Cancer

  44. CORRIELUS M, Hummel K, Valesano AL, Cheng J, et al
    Artificial intelligence-assisted triage of cervical biopsies using the low-cost, 3D-printed OpenFlexure Microscope: a paired comparative feasibility study.
    Int J Gynecol Cancer. 2026;36:104993.
    PubMed         Abstract available

  45. PARRA S, Aniyozova D, Phoolcharoen N, Ismail-Pratt I, et al
    Implementation of a national cervical cancer prevention program in Uzbekistan.
    Int J Gynecol Cancer. 2026 Oct 6:105652. doi: 10.1016/j.ijgc.2026.105652.
    PubMed        

  46. HAGEN KK, Eyjolfsdottir B, Dahl GF, Wang Y, et al
    Early post-operative complications after fertility-sparing surgery for cervical carcinoma: a retrospective study of a centralized national cohort of 127 consecutive women.
    Int J Gynecol Cancer. 2026;36:104986.
    PubMed         Abstract available

  47. VIVEROS-CARRENO D, Beshar I, Mora-Soto N, Cruz C, et al
    Follow-up after fertility-sparing surgery for cervical cancer: should human papillomavirus testing be used routinely? A narrative review.
    Int J Gynecol Cancer. 2026;36:104716.
    PubMed         Abstract available


    Int Rev Immunol

  48. MASHHADI ABOLGHASEM SHIRAZI M
    NF-kappaB signaling in persistent high-risk cervical HPV infection: Clinical evidence, molecular mechanisms, and translational therapeutic opportunities.
    Int Rev Immunol. 2026;45:430-448.
    PubMed         Abstract available


    Int Urogynecol J

  49. OTA K, Ota Y, Tasaka K, Shiota M, et al
    Clinically Significant Occult Uterine and Cervical Pathology in Women Undergoing Minimally Invasive Sacrocolpopexy With Concomitant Total Hysterectomy: A Retrospective Consecutive Case Series.
    Int Urogynecol J. 2026;37:3553-3560.
    PubMed         Abstract available


    J Appl Clin Med Phys

  50. ZHU H, Li J, Liang Y, Li W, et al
    A virtual physicist framework integrating dose prediction and large language models for automated treatment planning.
    J Appl Clin Med Phys. 2026;27:e70904.
    PubMed         Abstract available


    J Biomed Mater Res B Appl Biomater

  51. GOSECKA M, Gosecki M, Urbaniak M, Wielgus E, et al
    Dynamic Hydrogel-Mediated Co-Delivery of Clotrimazole and Nifuratel for Safe and Effective In Vivo Cervical Cancer Treatment.
    J Biomed Mater Res B Appl Biomater. 2026;114:e70172.
    PubMed         Abstract available


    J Cancer Surviv

  52. KNUTSEN A, Mikiver R, Redelius K, Uppugunduri S, et al
    Sexual symptoms in relation to curative pelvic radiotherapy in gynecological cancer patients.
    J Cancer Surviv. 2026;20:2148-2158.
    PubMed         Abstract available


    J Cell Biochem

  53. ZHANG L, Shen Q, Zhu J, Wang P, et al
    Calycosin Promotes Ferroptosis in Cervical Cancer via the AMPK/PI3K-TFEB-Autophagy-Lysosome Axis.
    J Cell Biochem. 2026;127:e70136.
    PubMed         Abstract available


    J Gynecol Obstet Hum Reprod

  54. DECAESTECKER R, Gondry J, Haem T, Vargas J, et al
    CytoHPV: Assessment of the predictive value of cytological analysis in relation to colposcopy-guided histology, before and after use of the primary HPV test.
    J Gynecol Obstet Hum Reprod. 2026;55:103283.
    PubMed         Abstract available

  55. CHABRE M, Mancini J, Maruani J, Carcopino X, et al
    Diagnostic performance of ASC-H cytology for detecting cervical high-grade intraepithelial lesions and cancer.
    J Gynecol Obstet Hum Reprod. 2026;55:103257.
    PubMed         Abstract available


    J Gynecol Oncol

  56. AHMED KS
    Comments with 'Cross-country inequalities and frontier analysis in global burden of cervical cancer: cross-sectional studies'.
    J Gynecol Oncol. 2026 Nov 3. doi: 10.3802/jgo.2026.
    PubMed        


    J Health Care Poor Underserved

  57. GUZMAN CEV, Martinez C, Layman KA, Rosenkranz SJ, et al
    High Risk Latinas Awareness and Interest in Self-collection for HPV Testing to Prevent Cervical Cancer.
    J Health Care Poor Underserved. 2026;37:1389-1397.
    PubMed         Abstract available


    J Nutr Sci Vitaminol (Tokyo)

  58. LEE JW, Lim SY
    Effect of Fucoidan on Chemotherapy Efficacy via MAPK Pathway Modulation in Cervical Cancer.
    J Nutr Sci Vitaminol (Tokyo). 2026;72:391-397.
    PubMed         Abstract available


    J Pak Med Assoc

  59. NISAR B, Naseem N
    A comprehensive assessment of cervical cancer risk factors, screening modalities, and cytological outcomes.
    J Pak Med Assoc. 2026;76:1505-1509.
    PubMed         Abstract available


    J Proteome Res

  60. SU R, Sun A, Zhao T, Wang H, et al
    Quantitative Proteomics Reveals CBX4 Promotes Cervical Cancer Cell Proliferation by Regulating PFKFB4.
    J Proteome Res. 2026;25:6289-6300.
    PubMed         Abstract available


    J Transl Med

  61. FAN X, Jia Y, Li X, Huang M, et al
    SCG3 and YAP1 define molecular subtypes of small cell carcinoma of the cervix with divergent multi-omics features and prognostic outcomes.
    J Transl Med. 2026;24:1382.
    PubMed         Abstract available


    J Vis Exp

  62. SHI L, Khan MU
    Competing Endogenous Ribonucleic Acid Networks in Cervical Cancer: Mechanisms and Clinical Implications.
    J Vis Exp. 2026;.
    PubMed         Abstract available


    JCO Glob Oncol

  63. OBODOECHINA N, Smith JS, Kalulu P, Olusanya OA, et al
    Human Papillomavirus Genotypes Among Women With Invasive Cervical Cancer in Nigeria: A Scoping Review.
    JCO Glob Oncol. 2026;12:e2500022.
    PubMed         Abstract available


    Med Oncol

  64. CHEN J, Shi Y, Song Y, Liu G, et al
    Deciphering intratumoral heterogeneity: An interpretable radiopathologic framework for lymph node staging in early-stage cervical cancer.
    Med Oncol. 2026;43:369.
    PubMed         Abstract available


    medRxiv

  65. GWAYI S, Tomoka T, Chimusa ER, Fedoriw Y, et al
    Utilizing a Variant Prioritization Approach to Explore Genetic Variants in Cervical Cancer Cases among Malawian Women.
    medRxiv [Preprint]. 2026 Oct 26:2026.10.23.26364490.
    PubMed         Abstract available


    Mikrobiyol Bul

  66. KAZIMOVA L, Samadzade R, Hanelibeyli M, Hacisoy Y, et al
    [A Multicenter Retrospective Investigation of the Distribution of High-Risk HPV Genotypes Among Women Who Underwent HPV Testing in Azerbaijan].
    Mikrobiyol Bul. 2026;60:467-479.
    PubMed         Abstract available


    Mol Biol Rep

  67. CANDAN E, Ulker Z
    Gossypetin and luteolin, alone and with cisplatin, preferentially reduce MCF-7 breast cancer cell viability, whereas HeLa cervical cancer cells are refractory.
    Mol Biol Rep. 2026;53:1898.
    PubMed         Abstract available


    Nat Med


  68. Global, regional and national burden of cervical cancer in 1990-2023 with forecasts to 2050: a Global Burden of Disease study.
    Nat Med. 2026 Nov 2. doi: 10.1038/s41591-026-04729.
    PubMed         Abstract available


    Oncol Lett

  69. ZHANG L, Shen Q, Zhu J, Wang P, et al
    Calycosin synergistically promotes ferroptosis in cervical cancer cells by inducing epithelial-mesenchymal transition.
    Oncol Lett. 2026;32:557.
    PubMed         Abstract available


    Oncol Nurs Forum

  70. MUSLU A, Kilci Erciyas S
    The Effect of Health Anxiety on Cervical Cancer Attitudes and Beliefs.
    Oncol Nurs Forum. 2026;53:1-13.
    PubMed         Abstract available


    Oncol Res

  71. LIU X, Hua B, Xia Y, Huang H, et al
    Clinical Outcomes and Safety Profile of Camrelizumab Plus Famitinib in Persistent, Recurrent, or Metastatic Cervical Cancer.
    Oncol Res. 2026;34:21.
    PubMed         Abstract available


    PLoS One

  72. ASSEFA KT, Worku AG, Muche AA, Geremew BM, et al
    Enablers and barriers to human papillomavirus vaccination implementation among key stakeholders in Ethiopia: A qualitative study.
    PLoS One. 2026;21:e0361925.
    PubMed         Abstract available


    Public Health Nurs

  73. HOLST CG, Norgaard B, Marcussen M
    Women's Experience of Human Papillomavirus Self-Sampling in Cervical Cancer Screening Programs: A Scoping Review.
    Public Health Nurs. 2026 Nov 4. doi: 10.1111/phn.70203.
    PubMed         Abstract available


    Radiat Oncol

  74. LU Y, Wang L, Wang Y, Zhu Z, et al
    From synthesis to clinic: a task-specific framework for CT images metal artifact reduction in cervical brachytherapy.
    Radiat Oncol. 2026;21:152.
    PubMed         Abstract available


    Radiother Oncol

  75. MENARD J, Lusque A, Attal J, Carrie T, et al
    Impact of sexological follow-up on the sexual function of patients treated with chemo-radiotherapy and brachytherapy for locally advanced cervical cancer: results of the prospective FEMINICOL study.
    Radiother Oncol. 2026 Nov 5:111861. doi: 10.1016/j.radonc.2026.111861.
    PubMed         Abstract available


    Sex Health

  76. HUPPE LG, Okechukwu CA, Nanbigne T, Wang G, et al
    Pre-implementation assessment of upstream domains on the uptake of HPV self-sampling in safety-net settings: a scoping review.
    Sex Health. 2026;23:SH25187.
    PubMed         Abstract available


    Turk J Obstet Gynecol

  77. WIJAYANTO FPS, Simanjuntak AMT, Sirait PCNB, Kusnadi AAZ, et al
    PD-1/PD-L1 inhibitors plus chemotherapy in cervical cancer: A systematic review and meta-analysis.
    Turk J Obstet Gynecol. 2026 Nov 5. doi: 10.4274/tjod.galenos.2026.70923.
    PubMed         Abstract available


    Yakugaku Zasshi

  78. HIROTA Y, Hirata M, Kawakami M, Ozaki A, et al
    [Evaluation of the Educational Effects of Cervical Cancer and HPV Vaccine Education for Junior High School Students].
    Yakugaku Zasshi. 2026;146:959-967.
    PubMed         Abstract available


    Zhonghua Bing Li Xue Za Zhi

  79. CHEN J, Zhang HP, Zhong LL, Yang XW, et al
    [Human papillomavirus-associated cervical adenocarcinoma with yolk sac tumor differentiation: report of a case].
    Zhonghua Bing Li Xue Za Zhi. 2026;55:1094-1097.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum